Literature DB >> 7390700

Increased glomerular filtration rate and adrenocortical function in obese women.

K H Stokholm, J Brøchner-Mortensen, P F Hoilund-Carlsen.   

Abstract

Glomerular filtration rate (GFR) was measured in 16 obese women aged 28-48 years (overweight 65-110 per cent) and compared to GFR in 16 non-obese women of the same age and height. None of the women had signs of nephrourological disorders. GFR was determined from the total 51 Cr-EDTA plasma clearance measured by a simplified single-injection technique. In the obese women GFR (median value 129.0 ml/min) was significantly (P less than 0.002) increased by 24.6 per cent. The urinary excretion rate of 17-ketogenic steroids was increased in nine out of 14 obese women, but no correlation with GFR could be demonstrated. GFR in the obese women showed a significant positive correlation with the plasma cortisol concentration (rs = 0.77; P less than 0.01) and with the urinary excretion rate of free cortisol (rs = 0.78; P less than 0.01). Whether the correlation between the plasma cortisol concentration and the increased GFR in obese women is causal needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7390700

Source DB:  PubMed          Journal:  Int J Obes


  19 in total

1.  Impact of Weight Extremes on Clinical Outcomes in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Shan L Ward; Virginia Gildengorin; Stacey L Valentine; Anil Sapru; Martha A Q Curley; Neal Thomas; Douglas F Willson; Heidi R Flori
Journal:  Crit Care Med       Date:  2016-11       Impact factor: 7.598

Review 2.  Hyperfiltration nephropathy as a cause of late graft loss in renal transplantation.

Authors:  C Modlin; D Goldfarb; A C Novick
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Reduced insulin removal and erythrocyte insulin binding in obese children.

Authors:  M Knip; P Lautala; R Puukka
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

4.  Anesthetic Pharmacology and the Morbidly Obese Patient.

Authors:  Jerry Ingrande; Hendrikus Jm Lemmens
Journal:  Curr Anesthesiol Rep       Date:  2012-12-13

Review 5.  Clinical pharmacokinetics of drugs in obesity. An update.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

Review 6.  Drug disposition in obese humans. An update.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

7.  Obesity is associated with increased morbidity but not mortality in critically ill patients.

Authors:  Yasser Sakr; Christian Madl; Daniela Filipescu; Rui Moreno; Johan Groeneveld; Antonio Artigas; Konrad Reinhart; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

8.  Influence of obesity on sulfonamide disposition in Zucker rats.

Authors:  S Kaul; W A Ritschel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

9.  Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients.

Authors:  L A Bauer; W A Edwards; E P Dellinger; D A Simonowitz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Role of islet amyloid polypeptide secretion in insulin-resistant humans.

Authors:  A Kautzky-Willer; K Thomaseth; G Pacini; M Clodi; B Ludvik; C Streli; W Waldhäusl; R Prager
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.